Treatment of melanoma with alpha thymosin peptides in...

Details Treatment of melanoma with alpha thymosin peptides in... Treatment of melanoma with alpha thymosin peptides in...

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61K 31/4164 (2006.01) A61K 38/17 (2006.01) A61P 35/00 (2006.01) A61P 35/04 (2006.01)

Patent

CA 2709027

Melanoma or a metastasis thereof is treated in a human patient in a combination therapy which includes administering a melanoma-treating combination to a human melanoma patient during a treatment regimen, the combination including an alpha thymosin peptide and antibodies against cytotoxic T lymphocyte-associated antigen 4 (CTLA4).

Un mélanome ou une métastase de celui-ci est traité chez un patient humain par une thérapie d'association qui comprend l'administration d'une association de traitement de mélanome à un patient humain atteint d'un mélanome lors d'un schéma thérapeutique, l'association comprenant un peptide d'alpha-thymosine et des anticorps contre l'antigène 4 associé au lymphocyte T cytotoxique (CTLA4).

Affiliated with

Also associated with

Rating

Treatment of melanoma with alpha thymosin peptides in... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of melanoma with alpha thymosin peptides in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of melanoma with alpha thymosin peptides in... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2090842